Immuneering Corporation Class A Share Price
NASDAQ: IMRX | Micro CapImmuneering Corporation Class A Stock Performance
Immuneering Corporation Class A Share Price Today
As of 29 October 2026, Immuneering Corporation Class A's share price is $3.90. The stock opened at $4.08, compared to its previous close of $4.00. During today's trading session, Immuneering Corporation Class A's share price traded between $3.89 and $4.10, with an average price of $4.00. Over the past 52 weeks, the stock has recorded a high of $8.47 and a low of $3.42. In terms of performance, Immuneering Corporation Class A's share price has declined by 25.88% over the last six months and is down 43.35% on a year-on-year basis.
Immuneering Corporation Class A Share Price Chart
Immuneering Corporation Class A Quarterly Profit & Loss
All figures in USD
Immuneering Corporation Class A Annual Profit & Loss
All figures in USD
About Immuneering Corporation Class A
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
Immuneering Corporation Class A Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $4.11 | $3.92 | -4.74% |
Sep 2026 | $4.92 | $4.11 | -21.34% |
Aug 2026 | $4.13 | $5.22 | +26.51% |
Jul 2026 | $5.10 | $4.13 | -17.23% |
Jun 2026 | $5.65 | $4.99 | -13.67% |
May 2026 | $5.21 | $5.78 | +9.99% |
Apr 2026 | $5.29 | $5.25 | -0.10% |
Mar 2026 | $4.86 | $5.26 | +4.99% |
Feb 2026 | $4.62 | $5.01 | +8.09% |
Jan 2026 | $6.53 | $4.63 | -29.45% |
Dec 2025 | $7.47 | $6.57 | -14.34% |
Nov 2025 | $6.75 | $7.67 | +11.56% |